Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the…
History, Art & Companies
Explore the main themes, entities and connections around Kenvue. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
consumer company johnson ipo billion new 2025 2023 ceo health november brands would 2021 kimberly-clark division 2022 johnson's aveeno band-aid
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Kenvue | Area served | Worldwide | 1.00 | infobox |
| Kenvue | Founded | February 23, 2022; 4 years ago (2022-02-23) | 1.00 | infobox |
| Kenvue | Headquarters | Summit, New Jersey, U.S. | 1.00 | infobox |
| Kenvue | Industry | Consumer products | 1.00 | infobox |
| Kenvue | Key people | Kirk Perry (CEO) | 1.00 | infobox |
| Kenvue | Key people | Larry Merlo (chairman) | 1.00 | infobox |
| Kenvue | Net income | US$1.47 billion (2025) | 1.00 | infobox |
| Kenvue | Number of employees | c. 22,000 (2025) | 1.00 | infobox |
| Kenvue | Operating income | US$2.41 billion (2025) | 1.00 | infobox |
| Kenvue | Predecessor | Johnson & Johnson (consumer health division) | 1.00 | infobox |
| Kenvue | Predecessor | Pfizer Consumer Health (first incarnation) | 1.00 | infobox |
| Kenvue | Predecessor | Pharmacia & Upjohn (consumer health division) | 1.00 | infobox |
| Kenvue | Predecessor | Warner–Lambert (consumer health division) | 1.00 | infobox |
| Kenvue | Predecessor | Glaxo Wellcome (consumer health division in most territories)[note 1] | 1.00 | infobox |
| Kenvue | Products | Aveeno | 1.00 | infobox |
| Kenvue | Products | Band-Aid | 1.00 | infobox |
| Kenvue | Products | Benadryl | 1.00 | infobox |
| Kenvue | Products | Johnson's Baby | 1.00 | infobox |
| Kenvue | Products | Listerine | 1.00 | infobox |
| Kenvue | Products | Lactaid | 1.00 | infobox |
| Kenvue | Products | Mylanta | 1.00 | infobox |
| Kenvue | Products | Neutrogena | 1.00 | infobox |
| Kenvue | Products | Trosyd | 1.00 | infobox |
| Kenvue | Products | Calpol | 1.00 | infobox |
| Kenvue | Products | Tylenol | 1.00 | infobox |
| Kenvue | Products | Visine | 1.00 | infobox |
| Kenvue | Revenue | US$15.1 billion (2025) | 1.00 | infobox |
| Kenvue | Subsidiaries | McNeil Consumer Healthcare | 1.00 | infobox |
| Kenvue | Total assets | US$27.1 billion (2025) | 1.00 | infobox |
| Kenvue | Total equity | US$10.8 billion (2025) | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.